Objectives: To compare levels of HbA 2 , HbE, HbF, and red cell parameters (total Hb, PCV, MCV, and MCH) and also determine their appropriated cut-off points for initial discrimination between homozygous HbE with and without α 0 -thalassemia trait.
-thalassemia trait.
Methods: Hb analysis results from capillary electrophoresis (CE) and red cell parameters of homozygous HbE without α 0 -thalassemia trait (n = 41) and with α 0 -thalassemia trait (n = 17) were reviewed.
Results: The MCV, MCH, and HbE of homozygous HbE with α 0 -thalassemia trait were significantly lower than those of homozygous HbE without α 0 -thalassemia, while HbA 2 levels of the former were significantly higher than those of the latter. HbA 2 at a cut-off point of 5.3% had 69.0% efficiency in discrimination between the 2 groups. It could also reduce 56.1% of homozygous HbE samples for α 0 -thalassemia testing.
Conclusions:
The elevated HbA 2 ≥5.3% is a useful marker for initial discrimination between homozygous HbE with and without α 0 -thalassemia trait.
Key words: α 0 -thalassemia, capillary electrophoresis, HbA 2 , homozygous HbE, screening Hemoglobin (Hb) E [β26 (B8) Glu→Lys, GAG>AAG; HBB: c.79G>A] is a β-hemoglobin variant caused by G>A substitution at codon 26 of β-globin chain that leads to a change of the amino acids from glutamic acid to lysine. This abnormal Hb occurs with a high frequency throughout many Asian countries. The overall prevalence of HbE in Thailand is about 20% to 30%, with the highest frequency of about 50% observed in the northeastern Thai population. 
Materials and Methods
This report is a retrospective study. The red cell parameters were measured by automated blood counter (ADVIA 2120i, Siemens, Munich, Germany), while the Hb typing was analyzed by CE (Sebia, Norcross, GA, USA). In addition, the molecular diagnosis for α 0 -thalassemia Southeast Asian (SEA) and Thai type deletions was performed by using the Relative Quantitative PCR, or the real-time PCR with SYBR Green1 and high resolution melting (HRM) analysis as previously described.
11,12
Statistical analysis
The levels of total Hb, PCV, MCV, MCH, HbA 2 , HbE, and HbF were presented by mean and standard deviation (SD). Statistical analyses were performed using SPSS software package (Statistical Package for the Social Sciences 11.0, Chicago, IL, USA). Mean levels of these red cell parameters were compared between the 2 groups of homozygous HbE with and without α 0 -thalassemia trait by using Compare
Means with Independent Samples t-test. The P < 0.05 was considered statistically significant.
Results
The hematological data of 41 homozygous HbE without α 0 -thalassemia trait were obtained from the AMS-CSC, and those of 17 homozygous HbE with α 0 -thalassemia SEA type deletion trait were obtained from 4 sites: 8 from AMS-CSC, 5 RMSc.CM, 3 CMHPH, and 1 from the Department of Pathology, Faculty of Medicine, Prince of Songkla University. The mean ± SD age of 58 samples was 31.8 ± 13.7 years (range 1 to 62 years). Mean levels of MCV and MCH of homozygous HbE with α 0 -thalassemia SEA type deletion trait were significantly lower than those of homozygous HbE without α 0 -thalassemia trait, while the levels of total Hb and PCV among the 2 groups were comparable (Table 1 and Figure 1 ).
The HbE levels of homozygous HbE with α 0 -thalassemia SEA type deletion trait were significantly lower than those of homozygous HbE without α 0 -thalassemia trait. On the other hand, HbA 2 levels of the former were significantly higher than those of the latter, while HbF levels among the 2 groups were comparable (Table 1 and Figure 2 
Discussion
Even though carriers of the α 0 -thalassemia do not manifest any clinical symptoms, couples who are both carriers have a 25% chance for conceiving a homozygous fetus, which manifests as Bart's hydrops fetallis, the most severe thalassemic syndrome. Therefore, laboratory investigations are essential for genetic counseling, prevention, and control programs for Bart's hydrops fetallis. A marked reduction of HbE level at less than 25% is used for discrimination between heterozygous HbE with and without α 0 -thalassemia trait. 6, 7 However,
this cannot be applied to a homozygous HbE because the Hb analysis presents almost a 100 percentage of HbE. 8, 13 The CE has proven superior to HPLC and LPLC in the measurement of HbA 2 because it can separate HbA 2 from HbE. 9 Thus, in our current study we found that the homozygous HbE with α 0 -thalassemia trait had a significantly higher HbA 2 levels than the homozygous HbE without α 0 -thalassemia trait. Consistency with the previous study showed that the increased HbA 2 level at higher than 4.5% was a useful marker for differentiation of homozygous HbE with and without α 0 -thalassemia trait. Thus, it could reduce 24.8% of homozygous HbE samples for α 0 -thalassemia testing.
14 In the present study, the lowest HbA 2 level found in a homozygous HbE with α 0 -thalassemia trait was 5.3%. Therefore, the HbA 2 at the cut-off point of ≥5.3% was used for discrimination between homozygous HbE with and without α 0 -thalassemia trait and it showed 100.0% sensitivity, 56.1% specificity, 48.6% positive predictive value (PPV), 100.0% negative predictive value (NPV) and 69.0% efficiency. It could also reduce 23 of 41 (56.1%) of homozygous HbE samples for α 0 -thalassemia testing. However, the elevated HbA 2 (5.5%) had also been found in a case of homozygous HbE with homozygous α
). 14 In the present study, we cannot rule out these cases in samples which had HbA 2 equal or higher than 5.3% and negative result for α 0 -thalassemia diagnosis. The molecular analysis for detection of α + -thalassemia (3.7 and 4.2 kb deletions) is not routinely performed in our laboratory since the α + -thalassemia usually has a totally silent phenotype. 15 In addition, a prenatal diagnosis is not compulsory in a couple who has a fetus with risk for deletional HbH diseases (--/-α).
HbF levels among the 2 groups of homozygous HbE with and without α 0 -thalassemia trait were comparable. Thus, they cannot be used as a marker of the co-inheritance of
Figure 1
The red cell parameters (total Hb, PCV, MCV, and MCH) among the 2 groups of homozygous HbE without α 16, 17 In conclusion, our results indicated that the increased HbA 2 level is a useful marker to differentiate the homozygous HbE with and without α 0 -thalassemia trait. All of homozygous HbE with α 0 -thalassemia trait samples had HbA 2 level equal or higher than 5.3%. Thus, this cut-off point leads to a significant reduction in number of referral cases of homozygous HbE for molecular testing of α 0 -thalassemia in routine practice. 
Figure 2
The HbE, A 2 and F levels among the 2 groups of homozygous HbE without α 
